EUVIMEDEUVIMED entdecken
Crossref

Acetylation of MOB1 mediates polyphyllin II-reduced lysosome biogenesis in breast cancer by promoting the cytoplasmic retention of the YAP/TFEB coactivator complex

Yuliang Ren, Hui Wu, Miao Tan, Junjie Chen, Zhongqi Duan, Bingxin Zhu, Xuzhi Ruan, Qingqing Yu, Shuzhen Li, Xuewen Liu, Ying Liu, Yuan Si

Phytomedicine · 2024-01 · 122 · 155152

DOI: 10.1016/j.phymed.2023.155152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024-01. Verfasst von Yuliang Ren und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, China; Hubei Key …. Hauptthemen laut MEDLINE: Saponins, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Autophagy‒lysosome abnormalities are associated with the malignant progression of cancer. Transcription factor EB (TFEB) is the master transcriptional regulator of the autophagy‒lysosome machinery, and its abnormal activity is associated with autophagy-lysosome dysfunction. Polyphyllin II (PPII), an active steroidal saponin isolated from the rhizomes of Paris polyphylla, has been demonstrated to have antitumor activity. PURPOSE: Here, we explored the antitumor activity of PPII in breast cancer (BC) and further clarified its mechanism. METHODS: Autophagosome was detected by transmission electron microscopy, an autophagy indicator system, and western blot. The effect of PPII on lysosomal activity was evaluated by flow cytometry, a lysosomal cathepsin activity assay, and acridine orange staining. The effect of PPII on the signaling pathway was evaluated by Western blot, gene expression measurement, gene alterations. The binding of PPII and MOB1 was examined through a drug affinity responsive target stability assay. The pharmacokinetic parameters of PPII were evaluated in Sprague-Dawley rats. RESULTS: PPII exhibits therapeutic potential in BC by inducing the accumulation of autophagosome. PPII promotes the cytoplasmic retention of YAP/TFEB, which is responsible for the accumulation of autophagosome in BC. PPII activates Hippo signaling to promote cytoplasmic retention of YAP. PPII activates Hippo signaling by accelerating acetylation of MOB1 through a direct binding interaction. CONCLUSION: Taken together, these results confirm that acetylation of MOB1 mediates PPII-induced autophagosome accumulation in BC by promoting cytoplasmic retention of the YAP/TFEB coactivator complex. PPII is expected to be a drug candidate for the treatment of BC based on lysosomal biosynthesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SaponinsNeoplasmsAnimalsRatsAcetylationRats, Sprague-DawleyLysosomesAutophagyBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsSteroids

Stichwörter der Autor:innen

AutophagyBreast cancerMOB1Polyphyllin IITFEBYAP

Substanzen

SaponinsBasic Helix-Loop-Helix Leucine Zipper Transcription Factorspolyphyllin IISteroidsTFEB protein, rat

Autor:innen und Institutionen

  • Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, China; Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University…
  • Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, China; Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medici…
  • Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, China; Laboratory of Molecular Target Therapy of Cancer, Biomedical Research Institute,…
  • Laboratory of Molecular Target Therapy of Cancer, Biomedical Research Institute, Hubei University of Medicine, Shiyan, Hubei, China.

Zitieren

APA

Ren, Y., Wu, H., Tan, M., Chen, J., Duan, Z., Zhu, B., Ruan, X., Yu, Q., Li, S., Liu, X., Liu, Y., & Si, Y. (2024). Acetylation of MOB1 mediates polyphyllin II-reduced lysosome biogenesis in breast cancer by promoting the cytoplasmic retention of the YAP/TFEB coactivator complex. Phytomedicine, 122, 155152. https://doi.org/10.1016/j.phymed.2023.155152

Vancouver

Ren Y, Wu H, Tan M, Chen J, Duan Z, Zhu B, et al. Acetylation of MOB1 mediates polyphyllin II-reduced lysosome biogenesis in breast cancer by promoting the cytoplasmic retention of the YAP/TFEB coactivator complex. Phytomedicine. 2024;122:155152. doi:10.1016/j.phymed.2023.155152

BibTeX
@article{Ren2024,
  author = {Ren, Yuliang and Wu, Hui and Tan, Miao and Chen, Junjie and Duan, Zhongqi and Zhu, Bingxin and Ruan, Xuzhi and Yu, Qingqing and Li, Shuzhen and Liu, Xuewen and Liu, Ying and Si, Yuan},
  title = {Acetylation of MOB1 mediates polyphyllin II-reduced lysosome biogenesis in breast cancer by promoting the cytoplasmic retention of the YAP/TFEB coactivator complex},
  journal = {Phytomedicine},
  year = {2024},
  volume = {122},
  pages = {155152},
  doi = {10.1016/j.phymed.2023.155152}
}
Kostenlos starten →